Who We Are
Scheeling, Inc., commonly known as ‘Scheeling’ to our valued clients and business partners, is a national pharmaceutical company engaged in marketing and trading of the highest quality medicines manufactured by an ISO accredited and cGMP certified companies. Scheeling’s leadership and management paradigms are geared towards a perfect blend of career and cause-oriented initiatives.
How We Started
In mid May 2005, a group of professionals from different industries convened on its first strategic planning in Subic International Hotel. Spearheaded by the Founding President and CEO, Mario P. Chan, together with a long time colleague, Chief Finance Officer, Norberto K. De Luna, and other reputable business consultants and associates, they held the first session of brainstorming on cropping the best mission and vision for a possible venture that is yet to commence.
With the exceptional facilitation of our Chief Industrial Relations Officer, Mario Gil C. Jocson, Scheeling became a reality in May 31, 2005.
Scheeling was derived from the word, “schilling,” an old currency in Europe. As mentioned by our President and CEO during an interview in April 17, 2006 that was published in the Philippine Daily Inquirer, most of the raw materials being used in manufacturing our medicines come from Europe, hence the name Scheeling was born.
What We Do
We commit to be the chosen, trusted, and valued pharmacare partner
Products: To bring to the community effective, high quality, focused and market-relevant pharmaceuticals crafted with trusted partners
Customers: To provide total customer satisfaction and go the extra mile in order to cultivate healthier, happier, and long-term partnership
IBP-Technology: To provide at all times timely, accurate, and cost-effective internal services through processes that are well-structured, systematic, and competently managed
Scheeling Family: to continuously challenge, develop, and acknowledge the Scheeling Family as the primary resource of the company, in an environment of belonging, wellness, growth and reward